TScan Therapeutics
Amy Virbasius is a highly experienced scientist with a strong background in molecular and cell biology, holding a PhD from Northwestern University. Currently serving as a Principal Scientist at TScan Therapeutics, Amy has developed advanced RT-qPCR titering protocols and high throughput methods for lentivirus packaging. Previous roles include Senior Research Scientist and Laboratory Manager at the University of Massachusetts Medical School, where responsibilities included overseeing departmental operations and managing core facilities. Amy’s extensive experience encompasses designing innovative protocols and collaborating effectively with various stakeholders in both academic and therapeutic settings.